Lain, Edward
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Cosmetic
Clinical Evaluation of Next-Generation, Multi-Weight Hyaluronic Acid Plus Antioxidant Complex-Based Topical Formulations with Targeted Delivery to Enhance Skin Rejuvenation
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Rosacea
The Anti-Inflammatory Properties of Ivermectin and Brimonidine in the Treatment of Papulopustular Rosacea
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Cosmetic
Evaluation of Antioxidants’ Ability to Enhance Hyaluronic Acid-Based Topical Moisturizers
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 6 (2023): November 2023 Issue - Skin Cancer
Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 cm2 of the Face and Scalp in Patients with Actinic Keratosis: A Phase 3 Study
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Poster Presentations from FC20 Clinical Dermatology Conference®: Psoriasis
Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion for the Treatment of Plaque Psoriasis in Patients With 3-5% Body Surface Area
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast)
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Skin Cancer
Tirbanibulin Ointment 1% for Actinic Keratosis (AK): Pooled Data from Two Phase 3 Studies
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Cosmetic
Significantly Enhanced Improvement in Dryness, Roughness, Fine Lines and Radiance Following Daily Use of a Novel Multi-Weight Hyaluronic Acid Plus Antioxidant Complex-Based Lotion Compared to a Single-Weight HA Plus Ceramide-Based Lotion
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference) - Skin Cancer
Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Rosacea
Concurrent Administration of Ivermectin 1% Cream with Brimonidine 0.33% Gel Improves Efficacy and Tolerability in the Treatment of Moderate-to-Severe Rosacea
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23 - Seborrheic Dermatitis
Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Acne & Rosacea
Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Efficacy and Safety From a Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference) - Acne & Rosacea
Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference® - Acne & Rosacea
Efficacy and Safety of Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Polymeric Gel in Pediatric Participants with Acne
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Miscellaneous
Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Triple-Combination Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Moderate-to-Severe Acne: Efficacy and Safety Results From a Pooled Phase 3 Analysis
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Rapid Improvement with BPX-01 Minocycline Topical Gel in the Treatment of Moderate-to-Severe Inflammatory Acne Vulgaris: a Randomized, Double-Blind, Vehicle-Controlled Study
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Miscellaneous
A Randomized, Double-blind, Vehicle-Controlled Phase 2a Study Evaluating Once Daily Roflumilast Foam 0.3% in Patients With Moderate to Severe Seborrheic Dermatitis
Abstract
Poster PDF